The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The Neurobiology of Dopamine Signaling
Abstract
The brain contains 2 major groups of dopamine neurons. One is located in the arcuate nucleus of the hypothalamic median eminence and is involved in neuroendocrine regulation. The other, which is the subject of this article, is located in the ventral mesencephalon and projects to the forebrain. Although dopamine neurons are few (<1/100 000 brain neurons), they play an important role in regulating several aspects of basic brain function. They are necessary for the normal tasks of the regions they innervate, including motor behavior, motivation, and working memory. Dopamine neurons are also a central element in the brain reward system that controls the learning of many behaviors. Disappearance of nigrostriatal neurons results in Parkinson disease, whereas blockade of dopamine receptors has therapeutic effects in psychosis. Finally, artificial increase in dopamine transmission is the common mechanism of action of drugs of abuse that leads to addiction. Understanding how dopamine works is a major goal of neurobiology. Much progress has been accomplished in identifying the intracellular signaling pathways that underlie the immediate actions of dopamine and account for its long-term effects on brain properties. Recent findings allow us to identify molecules that may represent future therapeutic targets in neurology and psychiatry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Synaptic Vesicle Phosphoproteins and Regulation of Synaptic Function
Greengard, P., Valtorta, F., Czernik, A. J., & Benfenati, F. (1993) · Science · doi:10.1126/science.8430330 · Cited by 1,312
Self-citationThe Neurobiology of Slow Synaptic Transmission
Greengard, P. (2001) · Science · doi:10.1126/science.294.5544.1024 · Cited by 867
Self-citationDopamine neurons and their role in reward mechanisms
Schultz, W. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80007-4 · Cited by 766
Greengard, P., Allen, P. B., & Nairn, A. C. (1999) · Neuron · doi:10.1016/s0896-6273(00)80798-9 · Cited by 746
Self-citationDARPP-32: An Integrator of Neurotransmission
Svenningsson, P., Nishi, A., Fisone, G., Girault, J.-A., Nairn, A. C., & Greengard, P. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121415 · Cited by 720
Self-citationTHE OCCURRENCE, DISTRIBUTION AND PHYSIOLOGICAL ROLE OF CATECHOLAMINES IN THE NERVOUS SYSTEM
Carlsson, A. (1959) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07428-9 · Cited by 689
Hemmings, H. C., Greengard, P., Tung, H. Y. L., & Cohen, P. (1984) · Nature · doi:10.1038/310503a0 · Cited by 614
Self-citationPhosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons
Bibb, J. A., Snyder, G. L., Nishi, A., Yan, Z., Meijer, L., Fienberg, A. A., Tsai, L.-H., Kwon, Y. T., Girault, J.-A., Czernik, A. J., et al. (1999) · Nature · doi:10.1038/45251 · Cited by 552
Self-citationEnhancement of the Glutamate Response by cAMP-Dependent Protein Kinase in Hippocampal Neurons
Greengard, P., Jen, J., Nairn, A. C., & Stevens, C. F. (1991) · Science · doi:10.1126/science.1716001 · Cited by 498
Self-citationDARPP-32: Regulator of the Efficacy of Dopaminergic Neurotransmission
Fienberg, A. A., Hiroi, N., Mermelstein, P. G., Song, W.-J., Snyder, G. L., Nishi, A., Cheramy, A., O'Callaghan, J. P., Miller, D. B., Cole, D. G., et al. (1998) · Science · doi:10.1126/science.281.5378.838 · Cited by 491
Self-citationEffects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5
Bibb, J. A., Chen, J., Taylor, J. R., Svenningsson, P., Nishi, A., Snyder, G. L., Yan, Z., Sagawa, Z. K., Ouimet, C. C., Nairn, A. C., et al. (2001) · Nature · doi:10.1038/35066591 · Cited by 480
Self-citationSpinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines
Allen, P. B., Ouimet, C. C., & Greengard, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9956 · Cited by 444
Self-citationDopamine-Sensitive Adenyl Cyclase: Possible Role in Synaptic Transmission
Kebabian, J. W., & Greengard, P. (1971) · Science · doi:10.1126/science.174.4016.1346 · Cited by 421
Self-citationRegulation of Kainate Receptors by cAMP-Dependent Protein Kinase and Phosphatases
Wang, L.-Y., Salter, M. W., & MacDonald, J. F. (1991) · Science · doi:10.1126/science.1653455 · Cited by 395
Castellucci, V. F., Kandel, E. R., Schwartz, J. H., Wilson, F. D., Nairn, A. C., & Greengard, P. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7492 · Cited by 382
Self-citationRosenmund, C., Carr, D. W., Bergeson, S. E., Nilaver, G., Scott, J. D., & Westbrook, G. L. (1994) · Nature · doi:10.1038/368853a0 · Cited by 371
A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions
Ivar Walaas, S., Aswad, D. W., & Greengard, P. (1983) · Nature · doi:10.1038/301069a0 · Cited by 345
Self-citationSCHULMAN, H., & GREENGARD, P. (1978) · Nature · doi:10.1038/271478a0 · Cited by 336
Self-citationCyclic Nucleotide-dependent Protein Kinases
Kuo, J. F., & Greengard, P. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63097-2 · Cited by 335
Self-citationLoss of apolipoprotein E receptor LR11 in Alzheimer disease
Scherzer, C. R., Offe, K., Gearing, M., Rees, H. D., Fang, G., Heilman, C. J., Schaller, C., Bujo, H., Levey, A. I., & Lah, J. J. (2004) · Archives of Neurology · doi:10.1001/archneur.61.8.1200 · Cited by 316
Yan, Z., Hsieh–Wilson, L., Feng, J., Tomizawa, K., Allen, P. B., Fienberg, A. A., Nairn, A. C., & Greengard, P. (1999) · Nature Neuroscience · doi:10.1038/4516 · Cited by 288
Self-citationDifferential Expression of Cholesterol Hydroxylases in Alzheimer's Disease
Brown, J., Theisler, C., Silberman, S., Magnuson, D., Gottardi-Littell, N., Lee, J. M., Yager, D., Crowley, J., Sambamurti, K., Rahman, M. M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402324200 · Cited by 269
Koldamova, R. P., Lefterov, I. M., Ikonomovic, M. D., Skoko, J., Lefterov, P. I., Isanski, B. A., DeKosky, S. T., & Lazo, J. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300044200 · Cited by 237
Walaas, S., Nairn, A., & Greengard, P. (1983) · The Journal of Neuroscience · doi:10.1523/jneurosci.03-02-00302.1983 · Cited by 229
Self-citationBogdanovic, N., Bretillon, L., Lund, E. G., Diczfalusy, U., Lannfelt, L., Winblad, B., Russell, D. W., & Björkhem, I. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02277-7 · Cited by 213
Papassotiropoulos, A., Streffer, J. R., Tsolaki, M., Schmid, S., Thal, D., Nicosia, F., Iakovidou, V., Maddalena, A., Lütjohann, D., Ghebremedhin, E., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.1.29 · Cited by 208
Castellucci, V., Nairn, A., Greengard, P., Schwartz, J., & Kandel, E. (1982) · The Journal of Neuroscience · doi:10.1523/jneurosci.02-12-01673.1982 · Cited by 204
Self-citationPietrzik, C. U., Busse, T., Merriam, D. E., Weggen, S., & Koo, E. H. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf568 · Cited by 198
Expression of Liver X Receptor Target Genes Decreases Cellular Amyloid β Peptide Secretion
Sun, Y., Yao, J., Kim, T.-W., & Tall, A. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300760200 · Cited by 179
Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II
Girault, J. A., Hemmings, H. C., Williams, K. R., Nairn, A. C., & Greengard, P. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)88248-9 · Cited by 173
Self-citationDifferential expression of protein phosphatase 1 isoforms in mammalian brain
da Cruz e Silva, E., Fox, C., Ouimet, C., Gustafson, E., Watson, S., & Greengard, P. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03375.1995 · Cited by 163
Self-citationABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease
Wollmer, M. A., Streffer, J. R., Lütjohann, D., Tsolaki, M., Iakovidou, V., Hegi, T., Pasch, T., Jung, H. H., von Bergmann, K., Nitsch, R. M., et al. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00094-5 · Cited by 158
Adenosine 3′,5′-Monophosphate-Dependent Protein Kinase from Brain
Miyamoto, E., Kuo, J. F., & Greengard, P. (1969) · Science · doi:10.1126/science.165.3888.63 · Cited by 156
Self-citationPolymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease
Kölsch, H., Lütjohann, D., Ludwig, M. Z., Schulte, A., Ptok, U., Jessen, F., von Bergmann, K., Rao, M. L., Maier, W., & Heun, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001109 · Cited by 153
[23] Production of phosphorylation state-specific antibodies
Jczernik, A., Girault, J., Nairn, A. C., Chen, J., Snyder, G. L., Kebabian, J. W., & Greengard, P. (1991) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(91)01025-w · Cited by 132
Self-citationYau, J. L. W., Rasmuson, S., Andrew, R., Graham, M., Noble, J., Olsson, T., Fuchs, E., Lathe, R., & Seckl, J. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00438-x · Cited by 125
Co-localization of cholesterol, apolipoprotein E and fibrillar Aβ in amyloid plaques
Burns, M. P., Noble, W. J., Olm, V., Gaynor, K., Casey, E., LaFrancois, J. J., Wang, L., & Duff, K. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00647-2 · Cited by 120
Desdouits, F., Cohen, D., Nairn, A. C., Greengard, P., & Girault, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.15.8772 · Cited by 78
Self-citationWollmer, M. A., Streffer, J. R., Tsolaki, M., Grimaldi, L. M. E., Lütjohann, D., Thal, D. R., von Bergmann, K., Nitsch, R. M., Hock, C., & Papassotiropoulos, A. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001296 · Cited by 59
Sánchez, L., Álvarez, V., González, P., Gonz�lez, I., Álvarez, R., & Coto, E. (2001) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20010108)105:1<76::aid-ajmg1066>3.3.co;2-i · Cited by 53
Kölsch, H., Ptok, U., Mohamed, I., Schmitz, S., Rao, M. L., Maier, W., & Heun, R. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20043 · Cited by 45
Cited by
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
General Anesthesia and Altered States of Arousal: A Systems Neuroscience Analysis
Brown, E. N., Purdon, P. L., & Van Dort, C. J. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153200 · Cited by 539
Molecular and functional neuroscience in immunity
Pavlov, V. A., Chavan, S. S., & Tracey, K. J. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053158 · Cited by 444
Decoding Neural Circuits that Control Compulsive Sucrose Seeking
Nieh, E. H., Matthews, G. A., Allsop, S. A., Presbrey, K. N., Leppla, C. A., Wichmann, R., Neve, R., Wildes, C. P., & Tye, K. M. (2015) · Cell · doi:10.1016/j.cell.2015.01.003 · Cited by 402
A new three-dimensional model for emotions and monoamine neurotransmitters
Lövheim, H. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2011.11.016 · Cited by 357
Metadata
- Authors
- Girault, J.-A., & Greengard, P.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2004-05-01
- Volume
- 61
- Issue
- 5
- Pages
- 641
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2114715627
- Cited by
- 443
- References
- 42
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.